Prevention and Treatment of Cytomegalovirus Infection in Transplant Recipients
Over the past decade, significant progress has been made in the understanding of the molecular biology of cytomegalovirus (CMV) and the pathogenesis of CMV infection and disease. The introduction of antiviral agents with efficacy against CMV, coupled with rapid diagnostic techniques in the laborator...
Saved in:
Main Author: | Jutta K Preiksatis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1993-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/1993/572607 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prophylaxis of Cytomegalovirus in Renal Transplant Recipients
by: Allan S MacDonald, et al.
Published: (1993-01-01) -
Treatment of Cytomegalovirus Infection with Cidofovir and CMV Immune Globulin in a Lung Transplant Recipient
by: Heinrike Wilkens, et al.
Published: (2016-01-01) -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
by: José Luis Piñana, et al.
Published: (2024-08-01) -
The Role of The Cytomegalovirus Antigenemia Assay in the Detection and Prevention of Cytomegalovirus Syndrome and Disease in Solid Organ Transplant Recipients: A Review of the British Columbia Experience
by: Erica D Greanya, et al.
Published: (2005-01-01) -
Epstein-Barr Virus Infection in Transplant Recipients: Sumary of a Workshop on Surveillance, Prevention and Treatment
by: Upton Allen, et al.
Published: (2002-01-01)